FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2020”.
The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector.
As of the end of December 2020, we identify the following current VC trends in the US-Biotech sector:
- In December 2020 the investment volume in the US-Biotech sector amounted to USD 1,835m
- In 2020, overall Biotech funding in the USA reached USD 22,405m (+65% compared to 2019)
- Top 5 deals in 2020 exceed USD 300m each, largest transaction amounted to USD 755m in National Resilience, Inc.
To access the full report, please click here.